1 citations
,
May 2023 in “Journal of the American Academy of Dermatology”
Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.
A user who didn't respond well to minoxidil and finasteride is considering the role of IGF-1 in hair loss treatment effectiveness. They discuss the potential of using HGH to improve hair growth and other health issues, referencing several sources that suggest IGF-1 levels may influence hair loss and treatmentresponse.
The DNA Trichotest is considered unreliable for predicting hair loss treatmentresponses, and topical spironolactone is questioned for its effectiveness and safety in cis males. Finasteride and Dutasteride are recommended as more reliable treatments for androgenic alopecia.
User shares 4-month progress using finasteride, minoxidil, and microneedling for hair loss. Others discuss body hair, hair transplant possibilities, and user's treatmentresponse.
The user experienced male pattern baldness starting at 18, tried finasteride with no success, and switched to dutasteride, which halted hair loss. Minoxidil had no effect for them, while their brother, who didn't use AR inhibitors, maintained a juvenile hairline and successfully grew a beard with minoxidil, highlighting the unpredictable nature of genetics in hair loss and treatmentresponse.
The user discusses using Minoxidil and Finasteride for hair loss and plans to counteract potential facial aging from Minoxidil with tretinoin, a jade roller, dandelion root extract, and careful water and sodium intake. They also consider switching to topical Minoxidil and using supplements to enhance treatmentresponse.